BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19207554)

  • 1. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
    Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
    Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma.
    Chen JH; Chen KY; Ma HI; Yu CP; Nieh S; Lee HS; Jin JS
    Chin J Physiol; 2010 Aug; 53(4):234-44. PubMed ID: 21793333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
    Gao HW; Yu CP; Lee HS; Nieh S; Chiang CP; Wang WM; Jin JS
    Eur J Dermatol; 2010; 20(3):293-301. PubMed ID: 20400386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
    Vallböhmer D; Kuhn E; Warnecke-Eberz U; Brabender J; Hoffmann AC; Metzger R; Baldus SE; Drebber U; Hoelscher AH; Schneider PM
    Pharmacogenomics; 2008 Jun; 9(6):681-90. PubMed ID: 18518847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of fascin in human esophageal squamous cell carcinoma and its clinical significance].
    Qin YR; Tang H; Qiao JJ; Li FF; Ai JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1216-9. PubMed ID: 21764699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
    Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
    Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
    Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
    Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
    Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
    Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
    J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters.
    Tsai WC; Jin JS; Chang WK; Chan DC; Yeh MK; Cherng SC; Lin LF; Sheu LF; Chao YC
    J Histochem Cytochem; 2007 Sep; 55(9):955-62. PubMed ID: 17510372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.
    Mega S; Miyamoto M; Li L; Kadoya M; Takahashi R; Hase R; Kaneko H; Shichinohe T; Kawarada Y; Itoh T; Morikawa T; Kondo S
    Dis Esophagus; 2006; 19(5):355-9. PubMed ID: 16984532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
    Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
    Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of fascin expression in human gastric carcinoma.
    Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
    Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.